Mayukh Sukhatme Net Worth
Track Major Insider Updates On X/TwitterLast Updated: 2 months ago
Mayukh Sukhatme has an estimated net worth of at least $363.7 million*, as of Oct. 29, 2025. They own 18.8 million shares of ROIV stock. They have sold 1.3 million shares of ROIV stock since 2021, for an estimated $15.6 million.
Mayukh Sukhatme $ROIV SEC Form 4 Insider Trading
Mayukh Sukhatme has filed a total of 5 insider trades in $ROIV since 2021. Their most recent trade was a sale of 26,831 shares, made on Dec 17, 2025. Their largest trade was a sale of 689,495 shares, made on Dec 26, 2024. We estimate that they now own 18.8 million shares of $ROIV, worth an estimated $348.1 million.
Insider Trading at $ROIV
There have been a total of 228 insider trades reported at $ROIV since 2021, with 4.0 million shares purchased and 160.1 million shares sold. The most active insider traders in $ROIV stock have been Eric Venker, Rakhi Kumar, and Eric Venker. The most recent trade was a sale of 260,000 shares reported by Richard Pulik (CFO), made on Dec 23, 2025.
History of Insider Stock Trades by Mayukh Sukhatme
| Company Ticker | Purchase / Sale | Shares | Date | Disclosed (EST) |
|---|---|---|---|---|
ROIV
|
Sale | 26,831 | Dec 17, 2025 | Dec. 19, 2025, 10:04 p.m. |
|
ROIV
|
Sale | 10,796 | Dec 23, 2024 | Dec. 26, 2024, 10 p.m. |
|
ROIV
|
Sale | 185,946 | Dec 24, 2024 | Dec. 26, 2024, 10 p.m. |
|
ROIV
|
Sale | 689,495 | Dec 26, 2024 | Dec. 26, 2024, 10 p.m. |
|
ROIV
|
Sale | 412,584 | Dec 18, 2024 | Dec. 20, 2024, 10 p.m. |
$ROIV Executives and Stock Owners with Insider Trades
-
Eric Venker, President & COO
-
Rakhi Kumar, Chief Accounting Officer
-
Eric Venker, President & Immunovant CEO
-
Matthew Gline, CEO
-
Eric Venker, Chief Operating Officer
-
Mayukh Sukhatme, Pres&Chief Investment Officer
-
Richard Pulik, CFO
-
Mayukh Sukhatme, President & CIO
*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.